Supporters and Exhibitors
The COGI Congress would like to thank the supporters. It is with the support of the industry that COGI can continue in its mission to promote research and education and to disseminate new knowledge
Click on the logo to find out more about the company!
Gold Supporter
 |
Silver Supporters
 |
 |
 |
 |
Bronze Supporter
 |
Supporters
 |
 |
 |
Exhibitors
|
|
|
|
 |
IBSA is an international pharmaceutical company with headquarters in Lugano, Switzerland.
IBSA has developed an entirely new purification process in order to obtain a full range of highly purified, human gonadotrophins (hFSH, hMG and hCG). This patented process ensures both a high level of purity and the full respect of the natural glycosylation of these molecules.
Recently IBSA has marketed a novel ingenious system to deliver progesterone subcutaneously in an aqueous solution.
IBSA has managed to guarantee the highest quality of its products over the years due to the advantages of having a complete in-house manufacturing process in company-owned plants and thanks to a global quality system.
The company’s other franchises include osteoarthritis, pain-management, dermatology and thyroid diseases.
For more information please visit www.ibsagroup.com
IBSA has developed an entirely new purification process in order to obtain a full range of highly purified, human gonadotrophins (hFSH, hMG and hCG). This patented process ensures both a high level of purity and the full respect of the natural glycosylation of these molecules.
Recently IBSA has marketed a novel ingenious system to deliver progesterone subcutaneously in an aqueous solution.
IBSA has managed to guarantee the highest quality of its products over the years due to the advantages of having a complete in-house manufacturing process in company-owned plants and thanks to a global quality system.
The company’s other franchises include osteoarthritis, pain-management, dermatology and thyroid diseases.
For more information please visit www.ibsagroup.com
Gedeon Richter Plc., headquartered in Budapest, Hungary, is a major pharmaceutical company in Central Eastern Europe, with an expanding direct presence in Western Europe, China and Latin America. The product portfolio of Richter covers many important therapeutic areas, including Women’s Healthcare, Neuroscience and Cardiovascular medicine. Having the largest R&D unit in Central Eastern Europe and building upon its original focus in CNS disorders and its widely acknowledged steroid chemistry expertise, Richter has also become a significant player in the Women’s Healthcare field worldwide. Richter is also active in biosimilar product development.
For more information please visit www.richter.hu
For more information please visit www.richter.hu
Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Headquartered in Saint-Prex, Switzerland, Ferring is a leader in reproductive medicine and women’s health, and in specialty areas within gastroenterology and urology. Ferring has been developing treatments for mothers and babies for over 50 years and has a portfolio covering treatments from conception to birth. Founded in 1950, privately-owned Ferring now employs approximately 6,500 people worldwide, has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries.
For more information please visit www.ferring.com
For more information please visit www.ferring.com
Cryos International is here to help people on their path to parenthood. We are proud to provide specialized reproductive products, excellent customer care, and personal consultation – and we have done so for over 30 years. Our sperm come from all backgrounds and represents a large variety of ethnicities and phenotypes.
We have computerised systems that have been designed and worked on for over a decade, in order to ensure traceability and security. Furthermore, we are licensed according to the FDA and EU-Tissue Directive, setting the highest standards of quality and safety. For Cryos, it’s personal!
For more information about Cryos please visit dk.cryosinternational.com
We have computerised systems that have been designed and worked on for over a decade, in order to ensure traceability and security. Furthermore, we are licensed according to the FDA and EU-Tissue Directive, setting the highest standards of quality and safety. For Cryos, it’s personal!
For more information about Cryos please visit dk.cryosinternational.com
Fotona
With more than 50 years of experience, Fotona is a world-leading medical laser manufacturer recognized for its innovative, award-winning laser systems for applications in gynecology, surgery, aesthetics & dermatology and dentistry.
Fotona’s combined Er:YAG and Nd:YAG laser systems are proven to be less invasive and highly effective for clinical and aesthetic gynecology treatments. We are proud to be the first manufacturer to introduce SMOOTH® mode technology for a range of non-invasive laser vaginal treatments.
Our global distribution network spans across more than 90 countries, ensuring comprehensive support and service for Fotona laser users, including clinical training, workshops and hands-on demonstrations.
For more information about Fotona please visit www.fotona.com
With more than 50 years of experience, Fotona is a world-leading medical laser manufacturer recognized for its innovative, award-winning laser systems for applications in gynecology, surgery, aesthetics & dermatology and dentistry.
Fotona’s combined Er:YAG and Nd:YAG laser systems are proven to be less invasive and highly effective for clinical and aesthetic gynecology treatments. We are proud to be the first manufacturer to introduce SMOOTH® mode technology for a range of non-invasive laser vaginal treatments.
Our global distribution network spans across more than 90 countries, ensuring comprehensive support and service for Fotona laser users, including clinical training, workshops and hands-on demonstrations.
For more information about Fotona please visit www.fotona.com
KARL STORZ is a renowned manufacturer that is well established in all fields of endoscopy and can be considered as market leader in rigid endoscopy. The still family held company was founded in 1945 in Tuttlingen, Germany, and has grown to one with a worldwide presence and 8300 employees. KARL STORZ offers a range of both rigid and flexible endoscopes for a broad variety of applications. Today’s product range also includes fully integrated concepts for the OR and servicing.
For more information about Karl Storz please visit www.karlstorz.com
For more information about Karl Storz please visit www.karlstorz.com
Permanent International and European School in Perinatal, Neonatal and Reproductive Medicine.
Founded in Florence (Italy) in 2012, the School, inspired by the values of scientific culture, ethics and bioethics of life sciences, pursues the aim of promoting and enhancing the fundamental ideals of maternal infant medicine in its entire course: reproductive, periconceptional, maternal and child health periods. The School run courses of reproductive, perinatal and neonatal medicine and related disciplines, training programs, national and international conferences, congresses, debates, and any other event or action consistent with its objectives.
For more information about Preis School please visit www.preischool.com
Founded in Florence (Italy) in 2012, the School, inspired by the values of scientific culture, ethics and bioethics of life sciences, pursues the aim of promoting and enhancing the fundamental ideals of maternal infant medicine in its entire course: reproductive, periconceptional, maternal and child health periods. The School run courses of reproductive, perinatal and neonatal medicine and related disciplines, training programs, national and international conferences, congresses, debates, and any other event or action consistent with its objectives.
For more information about Preis School please visit www.preischool.com
Besins Healthcare is a privately held, global pharmaceutical company headquarter in Monaco. We are a world leader in novel therapies for gynecology and andrology. We have discovered ground-breaking technologies to improve patient well-being throughout our history. We developed several hormone therapies over the years including bioavailable natural progesterone by different routes of administration for pregnant women from conception until delivery and a natural testosterone transdermal gel for testosterone deficiency syndrome. We continue to be a leader in Estradiol Replacement Therapy with the first transdermal gel marketed in Europe. Our products are trusted and prescribed by healthcare professionals in more than 100 countries throughout the world.
For more information about Besins please visit www.besinshealthcare.co.uk
For more information about Besins please visit www.besinshealthcare.co.uk
At Janssen, we’re creating a future where disease is a thing of the past.
Janssen Pharmaceutica NV is one of the Janssen Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity and healing hopelessness with heart.
We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension
For more information about Janssen please visit www.janssen.com/
Janssen Pharmaceutica NV is one of the Janssen Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity and healing hopelessness with heart.
We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension
For more information about Janssen please visit www.janssen.com/
At Wisepress.com, Europe’s leading conference bookseller, attend around 200 conferences every year. We have an extensive range of books and journals relevant to the themes of this conference available at our booth. We also have a comprehensive range of STM titles available on our online bookshop. Follow us on Twitter @WisepressBooks.
Pantarhei Bioscience and Pantarhei Oncology
Pantarhei Bioscience (PRB) and Pantarhei Oncology (PRO)
focus on innovative drug development in respectively Woman’s Health
(WH) and Reproductive Endocrine Oncology (REO) based on the ability to identify, confirm and patent protect novel targets and
medical uses of existing hormones, biologicals, drugs and combinations thereof with a focus on clinical development and human safety.
Pantarhei adheres to the highest scientific standards for preclinical and clinical drug development and aims at publication of results in
peer-reviewed journals.
Major projects in the current Pantarhei pipelines include (i) Androgen Restored Contraception (ARC) to prevent the consequences of the
loss of testosterone caused by combined oral contraceptives (COCs) by adding dehydroepiandrosterone (DHEA) to COCs, (ii) the natural
fetal estrogen Estetrol (E4) for the (co)-treatment of advanced breast and prostate cancer and (iii) the use of the Zona Pellucida 3 (ZP3)
cancer antigen for immunotherapy of ZP3 expressing tumours such as ovarian, prostate, breast, colon and non-small-cell lung cancer
(NSCLC).
Pantarhei Bioscience / Pantarhei Oncology
Boulevard 17, 3707 BK Zeist, the Netherlands
info@pantarheibio.com, www.pantarheibio.com
info@pantarheioncology.nl, www.pantarheioncology.nl
Pantarhei Bioscience (PRB) and Pantarhei Oncology (PRO)
focus on innovative drug development in respectively Woman’s Health
(WH) and Reproductive Endocrine Oncology (REO) based on the ability to identify, confirm and patent protect novel targets and
medical uses of existing hormones, biologicals, drugs and combinations thereof with a focus on clinical development and human safety.
Pantarhei adheres to the highest scientific standards for preclinical and clinical drug development and aims at publication of results in
peer-reviewed journals.
Major projects in the current Pantarhei pipelines include (i) Androgen Restored Contraception (ARC) to prevent the consequences of the
loss of testosterone caused by combined oral contraceptives (COCs) by adding dehydroepiandrosterone (DHEA) to COCs, (ii) the natural
fetal estrogen Estetrol (E4) for the (co)-treatment of advanced breast and prostate cancer and (iii) the use of the Zona Pellucida 3 (ZP3)
cancer antigen for immunotherapy of ZP3 expressing tumours such as ovarian, prostate, breast, colon and non-small-cell lung cancer
(NSCLC).
Pantarhei Bioscience / Pantarhei Oncology
Boulevard 17, 3707 BK Zeist, the Netherlands
info@pantarheibio.com, www.pantarheibio.com
info@pantarheioncology.nl, www.pantarheioncology.nl